Skip Navigation LinksHome   |   Studies   |   Clinical Trials   |   Medicare Clinical Trials   |   Multiple Myeloma Medicare Study
  • Print
  • Share

Multiple Myeloma Medicare Study

Patients with Medicare are eligible for coverage of HCT for Multiple Myeloma if they participate in a CED clinical trial. Study development in progress.
Contact Anita D’Souza, MD with questions.
Check back for updates.

Last Updated: 10/12/2016 3:09 PM